These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 13613976)

  • 1. [Thromboelastographic activity of anti-platelet immune serum; studies in vitro].
    VULPIS N; DE MATTEIS F
    Policlinico Med; 1958 Oct; 65(5):269-301. PubMed ID: 13613976
    [No Abstract]   [Full Text] [Related]  

  • 2. Platelet collagen receptors and coagulation. A characteristic platelet response as possible target for antithrombotic treatment.
    Heemskerk JW; Kuijpers MJ; Munnix IC; Siljander PR
    Trends Cardiovasc Med; 2005 Apr; 15(3):86-92. PubMed ID: 16039967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical studies on platelet function. III. Study of changes in platelets and coagulation factor during blood storage].
    NISHIKAWA T
    Naika Hokan; 1961; 8():451-7. PubMed ID: 13729221
    [No Abstract]   [Full Text] [Related]  

  • 4. Coagulation activation and expression of CD40 ligand on platelets upon in vitro lipopolysaccharide-challenge in patients with unstable angina.
    Kälsch T; Nguyen XD; Elmas E; Grebert N; Süselbeck T; Klüter H; Borggrefe M; Dempfle CE
    Int J Cardiol; 2006 Aug; 111(2):217-23. PubMed ID: 16182391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet coagulation-protein interactions.
    Walsh PN
    Semin Thromb Hemost; 2004 Aug; 30(4):461-71. PubMed ID: 15354267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of platelet-dependent fibrin formation in a patient with Scott syndrome.
    Wielders SJ; Broers J; ten Cate H; Collins PW; Bevers EM; Lindhout T
    Thromb Haemost; 2009 Jul; 102(1):76-82. PubMed ID: 19572071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet microparticle membranes have 50- to 100-fold higher specific procoagulant activity than activated platelets.
    Sinauridze EI; Kireev DA; Popenko NY; Pichugin AV; Panteleev MA; Krymskaya OV; Ataullakhanov FI
    Thromb Haemost; 2007 Mar; 97(3):425-34. PubMed ID: 17334510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-vitro model for the ultrastructural study of the formation of thrombi in human platelets.
    Cerecedo D; González S; Mondragón M; Reyes E; Mondragón R
    Blood Coagul Fibrinolysis; 2006 Mar; 17(2):161-4. PubMed ID: 16479200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Aggregation function of platelets in persons with arterial hypertension and abdominal obesity].
    Simonenko VB; Medvedev NN; Nosova TIu
    Klin Med (Mosk); 2008; 86(5):22-4. PubMed ID: 18589711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of platelets and platelet-derived material on the activated partial thromboplastin time (Cephotest) coagulation test.
    Mendelsohn EE; Solum NO; Brosstad F
    Scand J Clin Lab Invest; 2005; 65(4):321-32. PubMed ID: 16076687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Research on experimental thrombopenia. III. Evaluation of the anti-platelet activity of an immune serum by means of agglutination of sensitized sheep erythrocytes with platelet antigen according to a modified Middlebrook-Dubos technic].
    ROSTI P; ZANGAGLIA O
    Boll Ist Sieroter Milan; 1955; 34(1-2):91-6. PubMed ID: 14378404
    [No Abstract]   [Full Text] [Related]  

  • 12. Platelet heterogeneity: variation in coagulation complexes on platelet subpopulations.
    Kempton CL; Hoffman M; Roberts HR; Monroe DM
    Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):861-6. PubMed ID: 15653564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Findings on platelet-rich blood transfusions in thrombocytopenia. a. Platelet survival; thromboelastographic determination. b. Thrombocytopoietic effect of blood transfusions].
    CARDONE U; PERICOLI F; PRATESI G; SALVATORI L; TORLONTANO G
    Riv Emoter Immunoematol; 1958; 5(4):257-65. PubMed ID: 13615161
    [No Abstract]   [Full Text] [Related]  

  • 14. Glass effect and platelet activity in Hageman plasma.
    OLLENDORFF P
    Thromb Diath Haemorrh; 1961 Jul; 6():104-17. PubMed ID: 13730854
    [No Abstract]   [Full Text] [Related]  

  • 15. Platelet activation and its patient-specific consequences.
    Smyth SS; Monroe DM; Wysokinski WE; McBane RD; Whiteheart SW; Becker RC; Steinhubl SR
    Thromb Res; 2008; 122(4):435-41. PubMed ID: 17949794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelets and tissue factor.
    Lösche W
    Platelets; 2005 Sep; 16(6):313-9. PubMed ID: 16194860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of procoagulant phospholipid interfering in tests for lupus anticoagulant.
    Exner T; Low J
    Thromb Res; 2004; 114(5-6):547-52. PubMed ID: 15507290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasopressin acts on platelets to generate procoagulant activity.
    Tomasiak M; Stelmach H; Rusak T; Ciborowski M; Radziwon P
    Blood Coagul Fibrinolysis; 2008 Oct; 19(7):615-24. PubMed ID: 18832900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemostyptic effect of oxidized cellulose on blood platelets.
    Másová L; Rysavá J; Krízová P; Suttnar J; Salaj P; Dyr JE; Homola J; Dostálek J; Myska K; Pecka M
    Sb Lek; 2003; 104(2):231-6. PubMed ID: 14577133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclosporine enhances platelet procoagulant activity.
    Tomasiak M; Rusak T; Gacko M; Stelmach H
    Nephrol Dial Transplant; 2007 Jun; 22(6):1750-6. PubMed ID: 17308321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.